Binding Sites are compared using Shaper.
For more information, please see the following publication:
Desaphy J. et al. Comparison and Druggability Prediction of protein-Ligand Binding sites from pharmacophore-annotated cavity shapes J. Chem. Inf. Model., 2012, 52(8), pp2287-2299
Binding Sites are considered as similar when the similarity value is greater than 0.44
| PDB ID | HET | Uniprot Name | EC Number |
|---|---|---|---|
| 2bak | AQZ | Mitogen-activated protein kinase 14 |
| PDB ID | HET | Uniprot Name | EC Number | Binding Site Similarity |
Align |
|---|---|---|---|---|---|
| 2bak | AQZ | Mitogen-activated protein kinase 14 | / | 1.000 | |
| 4a9y | AQZ | Mitogen-activated protein kinase 14 | / | 1.000 | |
| 3hv3 | R49 | Mitogen-activated protein kinase 14 | / | 0.574 | |
| 3gcq | 1BU | Mitogen-activated protein kinase 14 | / | 0.573 | |
| 3lfe | Z84 | Mitogen-activated protein kinase 14 | / | 0.560 | |
| 3be2 | RAJ | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.548 | |
| 3lfc | Z86 | Mitogen-activated protein kinase 14 | / | 0.537 | |
| 3l8s | BFF | Mitogen-activated protein kinase 14 | / | 0.529 | |
| 3iw8 | HIZ | Mitogen-activated protein kinase 14 | / | 0.519 | |
| 5bvw | 1N1 | Epithelial discoidin domain-containing receptor 1 | 2.7.10.1 | 0.516 | |
| 2rl5 | 2RL | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.511 | |
| 4fk3 | 325 | Serine/threonine-protein kinase B-raf | 2.7.11.1 | 0.510 | |
| 3prf | FP3 | Serine/threonine-protein kinase B-raf | 2.7.11.1 | 0.506 | |
| 2ewa | SB2 | Mitogen-activated protein kinase 14 | / | 0.505 | |
| 3ppk | FNI | Serine/threonine-protein kinase B-raf | 2.7.11.1 | 0.500 | |
| 4g31 | 0WH | Eukaryotic translation initiation factor 2-alpha kinase 3 | 2.7.11.1 | 0.499 | |
| 3bi6 | 396 | Wee1-like protein kinase | 2.7.10.2 | 0.496 | |
| 3oez | STI | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.491 | |
| 3cr0 | 809 | Wee1-like protein kinase | 2.7.10.2 | 0.488 | |
| 1x8b | 824 | Wee1-like protein kinase | 2.7.10.2 | 0.485 | |
| 4b2g | V1N | Uncharacterized protein | / | 0.484 | |
| 1uwh | BAX | Serine/threonine-protein kinase B-raf | 2.7.11.1 | 0.483 | |
| 2dq7 | STU | Tyrosine-protein kinase Fyn | 2.7.10.2 | 0.482 | |
| 1qcf | PP1 | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.481 | |
| 1w83 | L11 | Mitogen-activated protein kinase 14 | / | 0.475 | |
| 1crb | RTL | Retinol-binding protein 1 | / | 0.473 | |
| 3gc9 | B45 | Mitogen-activated protein kinase 11 | 2.7.11.24 | 0.473 | |
| 4feu | 537 | Aminoglycoside 3'-phosphotransferase AphA1-IAB | / | 0.473 | |
| 2z2w | 770 | Wee1-like protein kinase | 2.7.10.2 | 0.472 | |
| 2xkc | 4VQ | Serine/threonine-protein kinase Nek2 | 2.7.11.1 | 0.471 | |
| 4g34 | 924 | Eukaryotic translation initiation factor 2-alpha kinase 3 | 2.7.11.1 | 0.471 | |
| 1qpj | STU | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.470 | |
| 2oiq | STI | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.470 | |
| 3b8q | 900 | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.470 | |
| 4bj9 | UHB | Tankyrase-2 | 2.4.2.30 | 0.470 | |
| 4gkh | 0J9 | Aminoglycoside 3'-phosphotransferase AphA1-IAB | / | 0.468 | |
| 2vwu | 7X1 | Ephrin type-B receptor 4 | 2.7.10.1 | 0.467 | |
| 4gk3 | L87 | Ephrin type-A receptor 3 | 2.7.10.1 | 0.467 | |
| 1lco | PPY | Cytochrome b2, mitochondrial | 1.1.2.3 | 0.466 | |
| 1tdu | CB3 | Thymidylate synthase | / | 0.466 | |
| 2fb8 | 215 | Serine/threonine-protein kinase B-raf | 2.7.11.1 | 0.466 | |
| 4eev | L1X | Hepatocyte growth factor receptor | 2.7.10.1 | 0.466 | |
| 2p33 | J07 | Mitogen-activated protein kinase 10 | 2.7.11.24 | 0.465 | |
| 3ctj | 320 | Hepatocyte growth factor receptor | 2.7.10.1 | 0.465 | |
| 3tub | FPU | Tyrosine-protein kinase SYK | 2.7.10.2 | 0.463 | |
| 3zew | STU | Ephrin type-B receptor 4 | 2.7.10.1 | 0.463 | |
| 4hf4 | 15H | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.463 | |
| 2wi7 | 2KL | Heat shock protein HSP 90-alpha | / | 0.462 | |
| 2gtn | LIE | Mitogen-activated protein kinase 14 | / | 0.461 | |
| 4eh6 | 0ON | Mitogen-activated protein kinase 14 | / | 0.461 | |
| 1f4g | TP4 | Thymidylate synthase | / | 0.459 | |
| 2y98 | MIV | Mycinamicin IV hydroxylase/epoxidase | / | 0.459 | |
| 3eta | 351 | Insulin receptor | 2.7.10.1 | 0.459 | |
| 2jc6 | QPP | Calcium/calmodulin-dependent protein kinase type 1D | 2.7.11.17 | 0.458 | |
| 2p2h | 994 | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.458 | |
| 4wo5 | 324 | Serine/threonine-protein kinase B-raf | 2.7.11.1 | 0.458 | |
| 2gqg | 1N1 | Tyrosine-protein kinase ABL1 | 2.7.10.2 | 0.457 | |
| 2owb | 626 | Serine/threonine-protein kinase PLK1 | 2.7.11.21 | 0.457 | |
| 4iaq | 2GM | 5-hydroxytryptamine receptor 1B | / | 0.457 | |
| 1mkd | ZAR | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 3.1.4.53 | 0.456 | |
| 2in6 | 839 | Wee1-like protein kinase | 2.7.10.2 | 0.456 | |
| 3nrr | D16 | Bifunctional dihydrofolate reductase-thymidylate synthase | / | 0.456 | |
| 3nxo | D2B | Dihydrofolate reductase | 1.5.1.3 | 0.456 | |
| 1q41 | IXM | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.455 | |
| 2y6o | 1N1 | Ephrin type-A receptor 4 | 2.7.10.1 | 0.455 | |
| 3ft8 | MOJ | Heat shock protein HSP 90-alpha | / | 0.455 | |
| 3gyt | DL4 | Nuclear hormone receptor of the steroid/thyroid hormone receptors superfamily | / | 0.455 | |
| 4h1e | 10J | Beta-secretase 1 | 3.4.23.46 | 0.455 | |
| 1w06 | W05 | Isopenicillin N synthase | 1.21.3.1 | 0.454 | |
| 3q44 | D50 | M1 family aminopeptidase | 3.4.11 | 0.454 | |
| 4gki | 0JN | Aminoglycoside 3'-phosphotransferase AphA1-IAB | / | 0.454 | |
| 4nh8 | 2LC | Heat shock protein HSP 90-alpha | / | 0.454 | |
| 4ork | GDP | Bifunctional AAC/APH | 2.3.1 | 0.454 | |
| 2bkt | RPF | Renin | 3.4.23.15 | 0.453 | |
| 2rku | R78 | Serine/threonine-protein kinase PLK1 | 2.7.11.21 | 0.453 | |
| 3itz | P66 | Mitogen-activated protein kinase 14 | / | 0.453 | |
| 1n71 | COA | Aac(6')-Ii protein | / | 0.452 | |
| 1pmn | 984 | Mitogen-activated protein kinase 10 | 2.7.11.24 | 0.452 | |
| 2obx | INI | 6,7-dimethyl-8-ribityllumazine synthase 2 | 2.5.1.78 | 0.452 | |
| 1jnr | FAD | Adenylylsulfate reductase, subunit A (AprA) | / | 0.451 | |
| 1yw2 | PGJ | Mitogen-activated protein kinase 14 | / | 0.451 | |
| 2pr2 | DG1 | Enoyl-[acyl-carrier-protein] reductase [NADH] | 1.3.1.9 | 0.451 | |
| 2yvw | EPU | UDP-N-acetylglucosamine 1-carboxyvinyltransferase | / | 0.451 | |
| 3bhl | THG | Thymidylate synthase | / | 0.451 | |
| 3vjo | ANP | Epidermal growth factor receptor | 2.7.10.1 | 0.451 | |
| 3vs2 | VSB | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.451 | |
| 4ajd | F04 | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.451 | |
| 4fex | 0TO | Aminoglycoside 3'-phosphotransferase AphA1-IAB | / | 0.451 | |
| 4fhk | 0U0 | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.451 | |
| 4heu | 15J | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.451 | |
| 4l9k | EHF | Serum albumin | / | 0.451 | |
| 1h66 | FAD | NAD(P)H dehydrogenase [quinone] 1 | 1.6.5.2 | 0.450 | |
| 2a19 | ANP | Interferon-induced, double-stranded RNA-activated protein kinase | 2.7.11.1 | 0.450 | |
| 2ij7 | TPF | Mycocyclosin synthase | 1.14.21.9 | 0.450 | |
| 2wuf | KEM | 4,5:9,10-diseco-3-hydroxy-5,9,17-trioxoandrosta-1(10),2-diene-4-oate hydrolase | 3.7.1.17 | 0.450 | |
| 3cth | 319 | Hepatocyte growth factor receptor | 2.7.10.1 | 0.450 | |
| 3rsv | 3RS | Beta-secretase 1 | 3.4.23.46 | 0.450 | |
| 4eh3 | NAR | Mitogen-activated protein kinase 14 | / | 0.450 | |
| 1dxq | FAD | NAD(P)H dehydrogenase [quinone] 1 | 1.6.5.2 | 0.449 | |
| 1y2k | 7DE | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 3.1.4.53 | 0.449 | |
| 3d4b | DZD | NAD-dependent protein deacetylase | / | 0.449 | |
| 3s4q | NK0 | Mitogen-activated protein kinase 14 | / | 0.449 | |
| 3uib | SB2 | Putative mitogen-activated protein kinase | / | 0.449 | |
| 5f54 | TMP | Single-stranded-DNA-specific exonuclease | / | 0.449 | |
| 2iod | MYC | Dihydroflavonol 4-reductase | 1.1.1.219 | 0.448 | |
| 3rth | RTH | Beta-secretase 1 | 3.4.23.46 | 0.448 | |
| 4anq | VGH | ALK tyrosine kinase receptor | 2.7.10.1 | 0.448 | |
| 4dit | 0KD | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.448 | |
| 3rey | XAC | Adenosine receptor A2a | / | 0.448 | |
| 1o5r | FR9 | Adenosine deaminase | 3.5.4.4 | 0.447 | |
| 2ghm | LIC | Mitogen-activated protein kinase 14 | / | 0.447 | |
| 2xvd | AS6 | Ephrin type-B receptor 4 | 2.7.10.1 | 0.447 | |
| 3g6z | A7T | Renin | 3.4.23.15 | 0.447 | |
| 3gub | GUB | Death-associated protein kinase 1 | 2.7.11.1 | 0.447 | |
| 3zw3 | ZW3 | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.447 | |
| 4hni | 16W | Casein kinase I isoform epsilon | 2.7.11.1 | 0.447 | |
| 4qmx | H8H | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.447 | |
| 1hb1 | OCV | Isopenicillin N synthase | 1.21.3.1 | 0.446 | |
| 1udt | VIA | cGMP-specific 3',5'-cyclic phosphodiesterase | / | 0.446 | |
| 2exc | JNK | Mitogen-activated protein kinase 10 | 2.7.11.24 | 0.446 | |
| 2o8h | 227 | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.446 | |
| 2x7h | PFN | Prostaglandin reductase 3 | 1 | 0.446 | |
| 2yn8 | STU | Ephrin type-B receptor 4 | 2.7.10.1 | 0.446 | |
| 3ge7 | AFQ | Queuine tRNA-ribosyltransferase | 2.4.2.29 | 0.446 | |
| 1kyx | CRM | 6,7-dimethyl-8-ribityllumazine synthase | 2.5.1.78 | 0.445 | |
| 1qiq | ACC | Isopenicillin N synthase | 1.21.3.1 | 0.445 | |
| 2hog | 710 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.445 | |
| 2pbw | DOQ | Glutamate receptor ionotropic, kainate 1 | / | 0.445 | |
| 2vx1 | 7X8 | Ephrin type-B receptor 4 | 2.7.10.1 | 0.445 | |
| 3b8r | 887 | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.445 | |
| 3jsw | JAR | High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A | / | 0.445 | |
| 3pqb | VGP | Putative oxidoreductase | / | 0.445 | |
| 3qpo | PFR | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.445 | |
| 4equ | G6I | Serine/threonine-protein kinase 10 | 2.7.11.1 | 0.445 | |
| 4few | PP2 | Aminoglycoside 3'-phosphotransferase AphA1-IAB | / | 0.445 | |
| 4i6f | 1C7 | Serine/threonine-protein kinase PLK2 | 2.7.11.21 | 0.445 | |
| 4i6h | 1C8 | Serine/threonine-protein kinase PLK2 | 2.7.11.21 | 0.445 | |
| 1dr3 | HBI | Dihydrofolate reductase | 1.5.1.3 | 0.444 | |
| 1pkf | EPD | Epothilone C/D epoxidase | 1.14 | 0.444 | |
| 1uae | UD1 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase | / | 0.444 | |
| 2bdf | 24A | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.444 | |
| 2bu9 | HFV | Isopenicillin N synthase | 1.21.3.1 | 0.444 | |
| 2ga9 | AGS | Poly(A) polymerase catalytic subunit | 2.7.7.19 | 0.444 | |
| 2pl0 | STI | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.444 | |
| 3gc8 | B45 | Mitogen-activated protein kinase 11 | 2.7.11.24 | 0.444 | |
| 3hl0 | NAD | Maleylacetate reductase | / | 0.444 | |
| 3hu2 | AGS | Transitional endoplasmic reticulum ATPase | 3.6.4.6 | 0.444 | |
| 3vs1 | VSA | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.444 | |
| 5dp2 | NAP | CurF | / | 0.444 | |
| 1s7g | NAD | NAD-dependent protein deacylase 2 | / | 0.443 | |
| 2qoc | ANP | Ephrin type-A receptor 3 | 2.7.10.1 | 0.443 | |
| 3itu | IBM | cGMP-dependent 3',5'-cyclic phosphodiesterase | 3.1.4.17 | 0.443 | |
| 3slk | NDP | Polyketide synthase extender module 2 | / | 0.443 | |
| 3uzw | NAP | 3-oxo-5-beta-steroid 4-dehydrogenase | / | 0.443 | |
| 4a4l | 939 | Serine/threonine-protein kinase PLK1 | 2.7.11.21 | 0.443 | |
| 4awi | AQ2 | Mitogen-activated protein kinase 8 | 2.7.11.24 | 0.443 | |
| 4ddl | 0JQ | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.443 | |
| 4hw3 | 19G | Induced myeloid leukemia cell differentiation protein Mcl-1 | / | 0.443 | |
| 4hyu | 1BK | Mitogen-activated protein kinase 8 | 2.7.11.24 | 0.443 | |
| 4jbt | ASD | Cytochrome P450 monooxygenase | / | 0.443 | |
| 5c6c | CMP | cGMP-dependent protein kinase 2 | 2.7.11.12 | 0.443 | |
| 5fs9 | FAD | Apoptosis-inducing factor 1, mitochondrial | 1.1.1 | 0.443 | |
| 1tbb | ROL | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 3.1.4.53 | 0.442 | |
| 2hen | ADP | Ephrin type-B receptor 2 | 2.7.10.1 | 0.442 | |
| 3gu8 | 3GU | Death-associated protein kinase 1 | 2.7.11.1 | 0.442 | |
| 3gwf | FAD | Cyclohexanone monooxygenase | / | 0.442 | |
| 3p3z | P3Z | Putative cytochrome P450 | / | 0.442 | |
| 3qpn | PFK | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.442 | |
| 3vi7 | CBD | Hematopoietic prostaglandin D synthase | / | 0.442 | |
| 4fhd | 0TT | Spore photoproduct lyase | / | 0.442 | |
| 4xq9 | NAD | Homospermidine synthase | 2.5.1.44 | 0.442 | |
| 5e8x | STU | TGF-beta receptor type-1 | 2.7.11.30 | 0.442 | |
| 3qak | UKA | Adenosine receptor A2a | / | 0.442 | |
| 1f4f | TP3 | Thymidylate synthase | / | 0.441 | |
| 1y60 | H4M | 5,6,7,8-tetrahydromethanopterin hydro-lyase | 4.2.1.147 | 0.441 | |
| 2qoq | ANP | Ephrin type-A receptor 3 | 2.7.10.1 | 0.441 | |
| 2vn0 | TDZ | Cytochrome P450 2C8 | / | 0.441 | |
| 2vwy | 7X5 | Ephrin type-B receptor 4 | 2.7.10.1 | 0.441 | |
| 3gyu | DL7 | Nuclear hormone receptor of the steroid/thyroid hormone receptors superfamily | / | 0.441 | |
| 3qlf | PD5 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.441 | |
| 3vs5 | VSG | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.441 | |
| 4jib | 1L6 | cGMP-dependent 3',5'-cyclic phosphodiesterase | 3.1.4.17 | 0.441 | |
| 1blz | ACV | Isopenicillin N synthase | 1.21.3.1 | 0.440 | |
| 1byg | STU | Tyrosine-protein kinase CSK | / | 0.440 | |
| 1ouk | 084 | Mitogen-activated protein kinase 14 | / | 0.440 | |
| 1t13 | INI | 6,7-dimethyl-8-ribityllumazine synthase 2 | / | 0.440 | |
| 1tys | DHF | Thymidylate synthase | / | 0.440 | |
| 1u4d | DBQ | Activated CDC42 kinase 1 | / | 0.440 | |
| 1uym | PU3 | Heat shock protein HSP 90-beta | / | 0.440 | |
| 1xdd | AAY | Integrin alpha-L | / | 0.440 | |
| 2pui | ADP | Methylthioribose kinase | 2.7.1.100 | 0.440 | |
| 2y46 | MIV | Mycinamicin IV hydroxylase/epoxidase | / | 0.440 | |
| 2zb1 | GK4 | Mitogen-activated protein kinase 14 | / | 0.440 | |
| 3c7q | XIN | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.440 | |
| 3ocg | OCG | Mitogen-activated protein kinase 14 | / | 0.440 | |
| 3tti | KBI | Mitogen-activated protein kinase 10 | 2.7.11.24 | 0.440 | |
| 4a99 | MIY | TetX family tetracycline inactivation enzyme | / | 0.440 | |
| 4j52 | 1J3 | Serine/threonine-protein kinase PLK1 | 2.7.11.21 | 0.440 | |
| 4k33 | ACP | Fibroblast growth factor receptor 3 | 2.7.10.1 | 0.440 | |
| 5bt4 | 2LO | Bromodomain-containing protein 4 | / | 0.440 |